MPO and interstitial lung disease: Considering only MPO-ANCA ILD patients that eventually developed kidney disease, median MPO-ANCA titers at lung disease onset were 53 UI/mL (IQR 24.5–259.5), without statistically relevant difference (p = 0.0828) when compared to subjects without subsequent renal disease.